PAREXEL International CorporationWaltham, MA, United States (NASDAQ (GS): PRXL)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

PAREXEL Financial Statements

PAREXEL Financial Information

Company Type Public
Headquarters
Fiscal Year-End June
Annual Report Company Web Site
Investor Relations Company Web Site
Edgar Online logo
This data is provided as per license from EDGAR Online

PAREXEL Income Statement

  2008 2007 2006
Revenue ($ mil.) 1,163.0 918.1 760.0
Gross Profit ($ mil.) 334.9 254.8 208.7
Operating Income ($ mil.) 86.7 57.6 39.9
Total Net Income ($ mil.) 64.6 37.3 23.5
Diluted EPS (Net Income) 1.12 0.67 0.44
More PAREXEL financial information

PAREXEL Quarterly Statements

  Quarter Ending Jun 08 Quarter Ending Mar 08 Quarter Ending Dec 07
Revenue ($ mil.) 331.9 294.7 284.3
Gross Profit ($ mil.) 97.1 84.1 81.7
Operating Income ($ mil.) 26.9 22.7 20.5
Total Net Income ($ mil.) 25.0 14.2 11.5
Diluted EPS (Net Income) 0.43 0.25 0.20
More PAREXEL financial information

PAREXEL Stock Quote & Chart

10/10/08 15:00:04 EST • NASDAQ • 22.10 • Increased by 0.0000 • Increased by 0.0000 %
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
Detailed QuoteInteractive Stock Chart

PAREXEL Financial Ratios

  Company Industry
Median		 Market
Median1
Price/Sales Ratio 1.19 1.16 1.29
Price/Earnings Ratio 21.58 17.86 13.49
Price/Book Ratio 3.23 2.21 1.23
Price/Cash Flow Ratio 87.82 12.16 8.08
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.

Detailed PAREXEL Financial Ratios

PAREXEL Competitive Intelligence

Covance Pharmaceutical Product Development Quintiles Transnational
Annual Sales ($ mil.) 1,631.5 1,414.5 2,530.0
Employees 8,700 -- 18,000
Market Cap ($ mil.) 5,301.6 4,990.5 --

Competitive Landscape